Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...
AI coding tools are rapidly changing how we produce software, and the industry is embracing it—perhaps at the expense of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback